A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Gastric Cancer
Gastroesophageal-junction Cancer
Pancreatic Cancer

Interventions

DRUG: TST001
DRUG: Nivolumab Injection [Opdivo]
DRUG: mFOLFOX6
DRUG: Gemcitabine
DRUG: Albumin-Bound Paclitaxel

Sponsor

Suzhou Transcenta Therapeutics Co., Ltd.

Collaborators

[object Object]